Maha H. Hussain, MD
Northwestern Medical GroupPrimary Specialty
Hematology and Medical Oncology
Is your insurance accepted? Select plan
Accepts your insurance
Does not accept your insurance
Based on January 2026 plan details.
Accepted plans are subject to change. To be sure this medical professional is covered by your insurance plan, please contact your insurance carrier.
HealthBeat
Clinical Trials Provide More Options for Cancer Care
Learn more about clinical trials near you.
Breakthrough Prostate Cancer Therapy Targets Genes to Delay Progression
Medication may transform treatment approach for men with castrate-resistant prostate cancer and genetic mutations.
More HealthBeat ArticlesPractice Focus Areas
This medical professional has a particular interest or expertise in:
Education
- Medical Education:
-
MD, University of Baghdad College of Medicine - 1980
- Residency:
-
Detroit Medical Center/Wayne State University - 1986
- Fellowships:
-
Wayne State University School of Medicine - 1989
Languages Spoken
- Arabic
Board Certifications
- American Board of Internal Medicine - Internal Medicine (Certified)
- American Board of Internal Medicine - Medical Oncology (Certified)
Faculty Profile
Professor, Feinberg School of MedicinePractice Groups and Affiliations
- Medical Group:
- Northwestern Medical Group
- On Medical Staff At:
-
Northwestern Memorial Hospital
Ratings and Reviews
At Northwestern Medicine, our patient’s feedback is important to us. While different care providers have their own unique strengths, we strive to be as transparent as possible with our quality of care.
Read Ratings FAQsOverall Rating
1045 Ratings
Reviews from Patients
Reviews from Patients
August 14, 2026
5.0 star star star star starDr M. Hussain is an excellent physician. Her competence, thoroughness, knowledge empathy and professionalism are outstanding. Another exemplar quality is her ability and willingness to spot potential problems outside her scope of practice and make referrals to appropriate physicians. She is also willing to spend the time necessary to deal with individual patient's issues as needed
May 30, 2026
5.0 star star star star starShe is clearly a leader in this area. She keeps up on the latest available treatments. She actively meets with you, examines you, engages with you, and answers your questions. I have a lot of confidence in her.
March 21, 2026
5.0 star star star star starI'm just getting to know her, but everything in my first consultation went well. Her interview was concise, friendly and quite obviously driven by a wealth of knowledge and experience. The recommendations from the 1st consultation were urgently elevated. Having done the first post consultation test, it is obvious her suspicions were perfect.
March 03, 2026
5.0 star star star star starShe is a true world class oncologist. She takes wonderful care of her patients and makes us feel she listens, is up on the latest developments and data , and cares about us in addition to treating our diseases.
Disclosures
Industry Relationships
Consulting
Faculty member and/or their immediate family have engaged in activities such as speaking, advising, consulting, or providing educational programs for the following companies or other entities
- AbbVie, Inc.
- American Society for Clinical Investigation, Inc.
- AstraZeneca UK Limited
- Bayer HealthCare Pharmaceuticals, Inc.
- Bristol-Myers Squibb Company
- Johnson & Johnson
- MJH Life Sciences
External Professional Relationships
Pharmaceutical, device, and biotechnology companies frequently collaborate with basic scientists and physicians within an academic medical center to help advance science and improve patient care. These relationships are important in achieving scientific breakthroughs and in establishing the effectiveness and safety of promising new therapies. In order to assure objectivity in clinical research and patient care, the Northwestern University Feinberg School of Medicine (Feinberg), Northwestern Memorial HealthCare, Children's Hospital of Chicago Medical Center, and the Shirley Ryan AbilityLab have adopted integrity policies that require research and clinical faculty (in full-time, part-time, and unpaid/voluntary categories) to report compensated and uncompensated external industry relationships. Patients are encouraged to discuss these disclosures with their physician as well as to inquire as to how these relationships are overseen by Feinberg. To learn more about our Disclosure and Professional Integrity Policy, and the conflict of interest policies of our joint affiliate survey partners, please go to our Office for Regulatory Affairs Policies page.
HealthBeat
Clinical Trials Provide More Options for Cancer Care
Learn more about clinical trials near you.
Breakthrough Prostate Cancer Therapy Targets Genes to Delay Progression
Medication may transform treatment approach for men with castrate-resistant prostate cancer and genetic mutations.
More HealthBeat Articles